Mirae Asset Global Etfs Holdings Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,721 shares of VERA stock, worth $939,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,721
Previous 30,905
2.64%
Holding current value
$939,258
Previous $742,000
0.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$187 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$133 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$101 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$99.1 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.8 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $801M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...